Homocysteine and cognitive function in the elderly

Article Sidebar

PDF
Published: 2009-08-29
Keywords:
Plasma homocysteine, cognitive function, elderly

Main Article Content

Pusparini Pusparini
Department of Clinical Pathology, Medical Faculty, Trisakti University

Abstract

Dementia is prevalent among elderly people, and projections show that the number of affected might triple over the next 50 years, because of a large increase in the oldest segment of the population. The objective of this study was to investigate the relationship between cognitive function and serum homocysteine level. This study was a cross-sectional study carried out in Mampang district, South Jakarta. A total of 94 elderly people was recruited for this study consisting of 44 females and 50 males. In this study serum homocysteine level was assessed by fluorescent polarization immunoassay and cognitive function with the mini mental state examination (MMSE). In elderly women MMSE scores for plasma homocysteine concentrations of <11.7 mmol/L, 11.7-14.9 mmol/L and >14.9 mmol/L were 24.00 ± 3.68, 23.80 ± 6.51, and 20.80 ± 9.00 respectively, with p=0.000. In elderly men the MMSE scores for plasma homocysteine concentrations of <11.7 mmol/L, 11.7-14.9 mmol/L and >14.9 mmol/L were respectively 27.66 ± 2.06, 26.33 ± 3.79 and 24.03 ± 5.52 with p=0.008. Homocysteine concentrations of >14.9 mmol/L were more commonly found in males (66%) than in females (22.70%). The results of a regression analysis indicated that the factors influencing cognitive function were level of education (p=0.001) and age (p=0.035), whereas gender and homocysteine concentration did not affect cognitive function (p=0.554 and p=0.714, respectively). Plasma homocysteine concentration was inversely related to cognitive function. The most important factors affecting cognitive function were level of education and age.

Article Details

Issue

Vol. 28 No. 2 (2009)

Section

Review Article

The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.

How to Cite

Homocysteine and cognitive function in the elderly. (2009). Universa Medicina, 28(2), 106-116. https://www.univmed.org/ejurnal/index.php/medicina/article/view/236

References

Weir DG, Molloy AM. Microvascular disease and dementia in the elderly: are they related to hyperhomocysteinemia? Am J Clin Nutr 2000;71:859-60

Dufouil C, Alperovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003;53:214-21.

Roberts S, Sternberg S. Do nutritional supplements improve cognitive function in the elderly? Nutr 2003;19:976-80.

Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM, et al. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: result from the Sacramento area Latino study on aging. Am J Clin Nutr 2007;85:511-7.

Refsum H. Total homocysteine. Guidelines for determination in the clinical laboratory. Clinical laboratory news. AACC 2002;28:12-14.

Duel PB, Malinow MR. Homocysteine: an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol. 1997;8:28-34.

Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, A’Agostiono RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Eng J Med 2002;346: 476-83.

Mooijaart SP, Gussekloo J, Frolich M, Jolles J, Stott DJ, Westendorp RGJ. Homocysteine, vitamin B12 and folic acid and the risk of cognitive decline in old age: the Leiden 85-plus study. Am J Clin Nutr 2005;82:866-71.

Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005;82:636-43.

Ueland PM, Refsum H, Stabler SP, Malinow MR, Anderson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-78.

Garcia A, Haron Y, Pulman K, Hua L, Freedman M. Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study. J of Gerontol 2003;59A:1323-27.

Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs normative aging study. Am J Clin nutr 2005;82:627-35.

Garcia A, Zanibbi K. Homocysteine and cognitive function in elderly people. CMAJ 2004; 171:897-904.

Selhub J, Bagle LC, Miller J, Rosenberg IH. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 2000;71(suppl): 614S-20S.

Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forlani G, Tettamanti M, et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 2004;80:114-22.

Miller JW, Green R, Ramos MI, Allen LH, Mungas DM, Jagust WJ, et al. Homocysteine and cognitive function in the Sacramento area Latino study on aging. Am J Clin Nutr 2003;78:441-7.

Andres E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ 2004;171:1503-55.

Stott DJ, MacIntoch G, Lowe GDO, Rumley A, Mcmahon AD, Langhorne P, et al. Randomized controlled trial of homocysteine lowering vitamin treatment in elderly patients with vascular disease. Am J clin Nutr 2005;82:1320-6.

Lei F, Ng TP, Chuah L, Niti M, E HK. Homocysteine, folate, and vitamin B12 and cognitive performance in older Chinese adults: findings from Singapore longitudinal ageing study. Am J Clin Nutr 2006;84:1506-12.

Kruman II. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitoxicity. J Neuroscience 2000;20:6920-6.

Hsu KK, Sorond FA, Jen HC, Hashmi A, Milberg WP, Lipsitz LA. The role of homocysteine in multisystem age-related problems: a systematic review. J of Gerontol.2005;60A:1190-1201.

Massachusetts Medical Society. A controlled trial of homocysteine lowering and cognitive performance. N Eng J Med 2006;354:2764-72.

Miller JW. Assessing the association between vitamin B12 status and cognitive function in older adults. Am J Clin Nutr 2006;84:1259-60.

Krumdieck CL, Prince CW. Mechanisms of homocysteine toxicity on connective tissue: Implications for the morbidity of aging. J Nutr 2000;130:365S-8S.

Joosten E, Lesaffre E, Riezler R. Is metabolic evidence for vitamin B12 and folate deficiency more frequent in elderly patients with Alzheimer’s disease? Gerontol Biol Sci Med Sci 1997;52:76-9.

Bell IR, Edman JS, Selhub J. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand 1992;86:386-90.

Borroni B, Agosti C, Panzali AF, Di Luca M, Padovani A. Homocysteine, vitamin B6, and vascular disease in patients with Alzheimer disease. Neurology 2002;59:1475-6.

Miller JW, Green R, Mungas DM, Reed BR, Jagust WJ. Homocysteine, vitamin B6, and vascular disease in Alzheimer disease. Neurology 2002;58:1471-5.

Levitt AJ, Karlinsky H. Folate, vitamin B12 and cognitive impairment in patients with Alzheimer’s disease. Acta Psychiatr Scand 1992;86:301-5

Huadong Z, Juan D, Li JC, Wang YJ, Zhang M, He H. Study of the relationship between cigartette smoking, alcohol drinking and cognitive impairment among elderly people in China. Age and Ageing 2003;32:205-10.